In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a NomegestrolAcetate Drug Master File in Korea (NomegestrolAcetate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of NomegestrolAcetate. The MFDS reviews the NomegestrolAcetate KDMF as part of the drug registration process and uses the information provided in the NomegestrolAcetate KDMF to evaluate the safety and efficacy of the drug.
After submitting a NomegestrolAcetate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their NomegestrolAcetate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of NomegestrolAcetate suppliers with KDMF on PharmaCompass.